thanks to DJ and Mysterium for their recaps - makes the

New Post Public Reply Private Reply Replies (3) Message Board
thesmalls DJknows #10623
thanks to DJ and Mysterium for their recaps - makes the board worthwhile with this type of participation. i didnt get a chance to add notes yesterday and the two of you covered most of it well. i will add some of my own thoughts:

I was disappointed Bill wasnt on the call but as we now know - due to illness. my suggestion for the future would be this be put out ahead of time that his participation is tentative due to illness instead of leaving it vague. everything is suspect in the OTC world - nature of the beast. it happens - just be upfront. looking forward to his future participation on calls and appreciate his feedback/additional details today on this board.

i had trouble hearing some of the answers but in general, they seemed to do a sound job of answering them even if he wandered into the weeds on several of them. he seemed to struggle with a couple from the two callers but eventually got to the answer or properly deferred.

he addressed the relationship with IR group relative to $TPAC. can someone shed more light onto this for me/the board? if i understood correctly - they are a separate investment entity/group that has agreed to take on the role of IR/dissemination to increase exposure of TPAC to their group and beyond..? this would make them not a typical IR/PR firm but more of an investment house maybe branching out..? if so - that makes significantly more sense from a compensation/bias point. further, if that is correct or along the lines, why was this not further explained prior? would have eliminated significant confusion and consternation in the type of information and manner in which it was disseminated. however, might lead to some off disclosure issues internally with their group. possibly the reason they have been walking a very tight line with respect to "what's in it for them" questions.

PROS:
-he seemed to struggle with the revenue/guidance questions but it seemed like he committed to around $2.5MM of revenues on the low side for 2016 with revenues already on the books, current production commitments, and part of 2017 SLA revenues being put on the books in 2016. i missed the details on the 3MM part run but apparently DJ confirmed that was 3MM parts being currently run. is that what he was referring to with respect to "current production"?

-company committed to updated business plan/revenue guidance at end of 90 days which should come in the next 15-20 days. he wasnt sure if it would be month to month or quarterly but the takeaway for me was there is an updated, specific plan similar to prior one first laid out in 2014 and updated mid 2015. i have obviously beat the drum on the critical nature of this so it definitely stood out for me.

-$10MM seems to be guaranteed and looking if they can do better on terms for $85MM. also - if i understood correctly, this is regular paper and not dilutive. anyone understand this differently? seems they are looking to do better on points on the larger loan amount. i thought he got off into the weeds again on that answer and i had trouble following.

-confirmed SLAs are guaranteed/locked in. original announcements left a lot of wiggle room but as i understood it - the $135MM SLA is locked in for 10 years and will start in earnest 1Q17 and per the above, some of the revenue may be booked 4Q16. if so - i really believe they need to do a comprehensive PR at the end of the 90 days to show the investment world at large the transformation and locked in revenue streams of the emerging company (or as locked in as any of these agreements can be in this realm). big difference between "hope to" "expect" "may realize" etc to "agreement is locked in and will generate initial revenues 1Q17 if not before." wording is critical. remove ambiguity.

-thought he did a good job downplaying Boeing. while obviously a marquee name that garners a lot of attention - they have to get to the level where they can realistically supply/meet that level of demand. this was touched upon with second caller as well. at the same time, the relationship with Boeing and capabilities due to geography and capacity with partners seems to be strengthening for long term distribution/supply. any large manufacturer enjoys significant cost savings by issuing one PO instead of 20. big risk for both entities but will be tremendous if they pull it off. personally, i am more concerned about the ancillary POs and small OEM relationships which will drive short term revenue and demonstrate capability and the ability to scale. this is critical for cash flow and attractive financing.

-PPS. i thought they did a good job staying away from PPS discussions or direction. very difficult to do in OTC especially with the large preponderance of short term investors/traders. very easy to get caught in the weeds with these questions. thought they addressed it succinctly and got back on target/message with the ongoings that will affect PPS long term (even if they missed some key discussion points on dilution/share structure - see below).


CONS
-would liked to have heard resolute language on dilution/share structure. seems they ran out of time but he did allude that it would be covered in new plan released in 15-20 days. further, Bill tweeted several weeks ago about transformative news expected in/before September so this may coincide.

-flow of the call in general. if my understanding of their group is correct - this may address part of my concern here. normally, a call like this would have introduced the group/speakers and their respective roles, provided a summary of the Q/Year etc (in this group - I was expecting a summary of the 90 day reconstruction to date), provide pertinent numbers/guidance going forward, and THEN address presubmitted questions and finally go to Q&A. they provided an agenda (or four topics) prior. maybe i misunderstood that as a summary update and instead they were going to address questions submitted around those four topics.

-as stated above - still not really clear who/what this group is. while that may not be an issue for some (maybe most?), in my experience in the OTC realm as a long term investor and not a trader - this is very pertinent. i need to understand compensation, motivation, bias, and risk/reward so i can properly assess their long term "commitment" to the organization/shareholders. when "insiders" talk a great game and are filing Form 4s like the SEC will run out of them - that is a disconnect. maybe Bill can address that in more detail and clear up the confusion.

-timing. this CC really should have happened midway point in the reconstruction. moot point now and seems like lesson learned but the ambiguity and confusion from some of the tweets/emails prior allowed significant manipulation and price decline. while that may not matter "long term" - it is significant when convertible arrangements are in play and based on current share price. could that 70-80MM share increase since last reported have possibly only been half that? MMs have had free range to hammer away. daily FINRA short #s show a cyclic history of heavy shorting (sometimes 80-90% of daily trades on relatively high volume days) and then lightly numbers while the price retreats (covering) only to have several high shorted days again. while they cant eliminate it - some of it could have been mitigated. again - hopefully lesson learned.

-PRs. seems they took note of the lashback on the PR wording. again - if my understanding of their group is better or along the lines of what i suggested above - this may also help explain their wording in some of their responses. long story short - agreements like a $135MM SLA with locked in revenues need to be told to the investment community at large. no competitive advantage lost.


overall - i think the CC was a success. someone took a swing trying to knock the price down early on and cause a run but there was significant substance in the CC to prevent a collapse. hopefully they build upon this for future ones. finally, hopefully IR realizes that those of use that take time on here to delve into topics both pro and con are still fighting the same battle even when we are being critical.




FROM DJ:

Some highlights from this morning's CC with James of IR (own notes from what I heard):

No more 24% import tax advantage or savings because of a "Premier" status now between Boeing and TPAC. "James" said TPAC will be the "Main Distributor" or middleman managing the flow between Boeing and all suppliers (inventory going out of China = $160-200M).

Since becoming 'visible' TPAC is inundated with requests for all types of metal work and predominantly for four parts: bearings, rods, bushings and hinges.

BTL has been involved with TPAC since 2011... making part of the bearings' assembly. It made the bearings for the NAVAIR certification.

Raising funds through the USA FR is working on two areas: There's the EX-IM loan and I believe James said the China Sovereign Guaranteed Loan program. He added there's a contract set in stone to provide raw material at a pricing of $7-9M. And as part of that, USA FR is working on "Inventory Financing" whereby a company buys raw inventory from TPAC... and to me sounded like... pays up front. TPAC would rather use the EX-IM at full power to get $85M rather than just $10M with the current political situation. Needed are contracts to be able to get loans and that's what's now being worked on.

James emphasized they will always take out 20% to have as 'cash on hand'

In the past month, Boeing has changed its supply chain business asking suppliers to wait longer for payment ... up to 120 days. James said while others have issues with that, TPAC... with its new infrastructure... can accept that time table.

The new facility is operational and already producing product for the U.S. market. Expecting to produce 2-3M bearings plus other metal work. Should see revenues from production toward end of 2016.

TPAC has created a marketing division that's promoting Trans-Pacific Aerospace across seven continents. BTL is the seller.

Remember, contracts are needed to get loans.
TPAC has two SLAs with manufacturers its already working with now and a third signed. Each is worth $100-135M and is for a three year evaluation.

IR is just a reporting entity and through its initiatives would bring in a community of five million (potential shareholders?) through social media and other public relations operations during the period of reconstruction. Have to have cash on hand and raise the internal pps.

There are about 20 business days left to the 90-day reconstruction period.

Asked about getting an official press release (PR) out, James responded anything TPAC has done requires a PR but 90% of OTC companies offer PRs but almost 90% fail the shareholder. James added what they don't want to do is say something and need to retract it... "want to say something that would be absolute" ... so they want to complete the reconstruction period and have things finalized before putting out a PR... he said "there will be some PRs toward/by the end of the year."

Trans-Pacific Aerospace (TPAC) Stock Research Links

TPAC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 3

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 6

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 5

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 5

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 8

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading

Top 5 Most Recently Viewed Articles

Find Comfort and Assurance This Fall at Gate of Heaven

Updated Category News Views 97

Experience Comfort and Connection This Fall at Gate of Heaven This autumn, as the leaves turn and a spirit of reflection emerges, families are warmly invited to the Gate of Heaven Cemetery and Mausoleum for a special Fall Open House weekend. This event aims to foster connections among families while providing valuable insights into the significance of memorial planning....

Continue Reading
Lauren Cody to Lead Orangetheory Fitness as Brand President

Updated Category News Views 491

Lauren Cody Takes the Helm at Orangetheory Fitness Purpose Brands, LLC has exciting news! The organization, known for its significant contributions to the fitness, health, and wellness sector, is proudly announcing the appointment of Lauren Cody as the brand president of Orangetheory Fitness. With over twenty-five years of rich experience in leading substantial franchise...

Continue Reading
BofA Downgrades Nissan: Competition Fears and Sales Outlook

Updated Category News Views 126

BofA Downgrades Nissan Shares Due to Rising Competition BofA Securities has decided to downgrade Nissan Motor Co Ltd (OTC: NSANY), changing its stock rating from Buy to Underperform. This notable shift points to worries over various obstacles that might hinder the automaker's performance in the future. Revised Price Target Indicates Ongoing Challenges The investment firm...

Continue Reading
Momcozy Celebrates Community Spirit with Charity Contest Success

Updated Category News Views 206

Momcozy Celebrates the Winners of the Charity Contest Momcozy, a leading global mother and baby brand, is excited to share the results of its 'Love in Action' Charity Contest. This initiative was part of a larger campaign aimed at promoting comfort, health, and well-being for mothers everywhere. In total, $30,000 was awarded to three remarkable organizations that are...

Continue Reading
FDA Approves SELARSDI™: A New Era in Biologics

Updated Category News Views 647

Exciting News: SELARSDI™ Receives FDA Approval Teva Pharmaceuticals, in collaboration with Alvotech, has made significant strides in the field of biosimilars. Recently, the U.S. Food and Drug Administration (FDA) granted approval for SELARSDI™ (ustekinumab-aekn), marking it as interchangeable with the established biologic, Stelara® (ustekinumab). This...

Continue Reading